Will Intel file an 8-K exhibit disclosing anti-dilution, ratchet, or take-or-pay terms from the NVIDIA/SoftBank/USG strategic partner agreements by year-end 2026?

Committee explicitly frames strategic-partner economics as compound risk #3 'dark matter' — the default state is continued opacity, and management has been silent across 4 earnings calls. Confidential treatment requests routinely redact precisely these economic terms (ratchets, take-or-pay floors). However, the FY26 NCI guide quadrupling from $293M to $1.2B and the $1,796M MTM loss on escrowed shares both suggest embedded optionality that may force narrative explanation in the Q2 2026 DEF 14A or via SEC comment-letter cycle on Q3 2025 redactions. The question requires SPECIFIC language from one of four categories, which is a higher bar than narrative acknowledgment.

The SEC comment-letter cycle is the strongest YES driver — Q3 2025 8-Ks are roughly 6-9 months old at the analysis date, putting them squarely in the typical comment-letter window during 2026. If staff challenged redactions on the warrant agreements, Intel would be forced to file un-redacted or supplemental exhibits. Combined with the DEF 14A related-party narrative (Q2 2026) and a 9-month observation window, the probability of at least one of (a)/(b)/(c)/(d) surfacing is meaningful but still less than 50%. The asymmetry is that companies with negotiating leverage successfully resist disclosure — Intel has both Fortune 50 legal resources and USG counterparty cover.

The historical analogue (GlobalFoundries 2018-era) is decisive: USG-backed foundry deal terms surfaced only years later through litigation or bankruptcy — not through routine SEC filings. Intel's disclosure posture across 4 earnings calls is consistent with the management baseline of 'minimum required.' The four resolution categories (anti-dilution, take-or-pay, below-market floor, minimum capacity) are exactly the terms companies fight hardest to keep redacted because they are commercially sensitive AND politically sensitive (USG counterparty). Even if a DEF 14A discusses related-party economics, narrative prose typically does not include the specific contractual language types the resolver is looking for. The committee's own 'dark matter' framing is the strongest prior — they expect continued opacity.

Confidential treatment requests are the dominant force here. Companies that file strategic equity agreements as exhibits routinely redact pricing floors, anti-dilution mechanics, and take-or-pay volume commitments. The committee found ZERO disclosure across 4 earnings calls and zero exhibit-level economic terms — that pattern of silence is the strongest base rate. Counterweights: the $1,796M MTM loss is a large enough number that auditors may demand more detailed footnote disclosure in subsequent filings, which could leak specific mechanics. Also, the FY26 NCI guide of $1.2B (up from $293M) is hard to explain without describing some step-up structure. Net: NO is the more likely outcome but tail probability is meaningful.

The 9-month observation window matters more than any single catalyst. Across April-December 2026, Intel will file: Q1 2026 10-Q, DEF 14A (Q2), Q2 2026 10-Q, Q3 2026 10-Q, and likely several 8-Ks for ordinary-course events. Each filing is a potential disclosure surface. The committee specifically called out that the Q2 2026 DEF 14A will discuss related-party transactions — this is the highest-probability single event. Add SEC comment-letter pressure (which historically forces 30-40% of redaction disputes to be resolved with broader disclosure) and potential class-action discovery, and the cumulative probability rises. Still, the SPECIFIC language requirement (one of four categories) keeps this below coin-flip.

Management's revealed preference is silence. Across Q3 2025, Q4 2025, and the upcoming Q1 2026 calls, the disclosure posture has been 'minimum required.' The committee's framing of this as compound risk #3 'where the worst news has not been seen' explicitly encodes the expectation that this opacity persists. The four resolution categories are exactly the terms companies fight hardest to keep confidential because they are competitively damaging AND politically sensitive (USG involvement adds national-security cover for redaction). The DEF 14A narrative typically discusses related-party economics in summary form — 'the agreement provides for adjustments under certain circumstances' — which would NOT meet the resolution bar requiring specific language on (a)/(b)/(c)/(d).

Committee labeled this 'dark matter' compound risk #3 — the default expectation is no disclosure. Management silent across 4 earnings calls. CTRs routinely redact ratchets and take-or-pay terms. Counter-pressure from DEF 14A and SEC comment letters exists but typically produces narrative not specific contractual language. Lean NO.

The FY26 NCI guide of $1.2B (4x FY25's $293M) is hard to explain without disclosing some step-up structure. The $1,796M MTM loss on escrowed shares similarly implies embedded optionality that may force footnote expansion. DEF 14A Q2 2026 is the strongest single catalyst. But the four resolution categories are exactly the terms companies fight hardest to keep redacted, and Intel has Fortune 50 legal resources plus USG counterparty cover. Below coin-flip.

Historical USG-backed foundry deals (GlobalFoundries) only surfaced terms years later through litigation. No specific 2026 forcing event is identified. Committee explicitly expects continued opacity. The four named term categories are commercially and politically sensitive. The 9-month observation window contains multiple filing surfaces, but each individual filing has low conditional probability of containing the specific language required.